1Holland S J, Powell M J, Franci C, et al. Multiple roles for the receptor tyrosine kinase AXL in tumor formation[J]. Cancer Res, 2005,65 ( 20 ) : 9294-9303.
2Green J, Ikram M, Vyas J, et al. Overexpression of the AXL tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours [J]. Br J Cancer, 2006,94(10) : 1446-1451.
3Gschwind A, Fischer O M, Ulrich A. The discovery of receptor tyrosine kinases : targets for cancer therapy [J]. Nat Rev Cancer, 2004,4 (3): 361-370.
4Hafizi S, Dahlback B. Signalling and functional diversity within the AXL subfamily of receptor tyrosine kinases[J]. Cytokine Growth Factor Rev, 2006, 17 (4) : 295-304.
5Budagian V, Bulanova E, Orinska Z, et al .A promiscuous liaison between IL-15 receptor and AXL receptor tyrosinc kinase in cell death control [J].EMBO, 2005,24( 24 ) : 4260-4270.
6Munoz X, Sumoy L, Ramirez-Lorca R,et al. Human vitamin K-dependent GAS6:gene structure, allelic variation,and association with stroke [J]. Hum Mutat, 2004,23 (5) : 506-512.
7Sasaki T,Knyazev P G,Clout N J,et al.Structural basis for Gas6-AXL signaling [J]. EMBO J, 2006,25 ( 1 ) : 80-87.
8Lay J D, Hang C C, Huang J S, et al. Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL [J].Cancer Res, 2007,67(8):3878-3887.
9Shieh Y S, Lai C Y, Kao Y R, et al. Expression of AXL in lung adenocarcinoma and correlation with tumor progression [J].Neoplasia, 2005, 7( 12 ) : 1058-1064.
10Wu Y M, Robinson D R, Kung H J. Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells [J]. Cancer Res, 2004,64(20) : 7311-7320.
